{"entity":{"id":"nct07824349","kind":"trial","name":"JUR-003 in Adult Patients With Metastatic Prostate Cancer","aka":[],"tldr":"A phase 1 trial of JUR-003 run by Juri Biosciences, Inc., now recruiting.","summary":"JUR-003 in Adult Patients With Metastatic Prostate Cancer is a phase 1 interventional study registered as NCT07824349 by Juri Biosciences, Inc., with 210 participants planned, started 2026-09. Conditions recorded: Metastatic Castration Resistant Prostate Cancer, Oligometastatic Prostate Cancer (OMPC) and Metastatic Hormone Sensitive Prostate Cancer. Interventions recorded: JUR-003.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07824349","url":"https://clinicaltrials.gov/study/NCT07824349"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate-mcrpc","prostate","prostate-mhspc"],"sections":[],"technologies":[],"targets":[],"drugs":["jur-003"],"companies":["juri-biosciences"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07824349","phase":"1","setting":"A Phase 1a/1b Open Label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of JUR-003 in Adult Patients With Metastatic Prostate Cancer","sponsor":"Juri Biosciences, Inc.","enrolled":210,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07824349/","neighbours":{"cancer":[{"id":"prostate-mcrpc","kind":"cancer","name":"Metastatic castration-resistant prostate cancer","route":"/cancers/prostate-mcrpc/"},{"id":"prostate-mhspc","kind":"cancer","name":"Metastatic hormone-sensitive prostate cancer","route":"/cancers/prostate-mhspc/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"jur-003","kind":"drug","name":"JUR-003","route":"/drugs/jur-003/"}],"company":[{"id":"juri-biosciences","kind":"company","name":"Juri Biosciences","route":"/companies/juri-biosciences/"}]}}